TOKYO - Mitsui & Co
plans to invest 4 billion yen (US$35.7 million) over the
next five years to develop new businesses in the
environmental and medical fields based on the
exploitation of nanomaterials.
In the medical
field, nanotech materials will be used to devise ways of
manufacturing drugs from biomass efficiently. The
project will also seek to find a way of combining
inorganic materials with proteins for applications in
Nanotech materials will
also be used to develop microorganism-monitoring systems
aimed at improving the environment.
As part of
this project, Mitsui will increase the capitalization of
subsidiary Device Nanotech Research Institute Inc.
Outside scientists, including a professor at
Waseda University, will also participate in actual
The trading firm plans to turn profits
in the future by licensing technologies and selling some
of these businesses outright.
Sep 27, 2003
material from Asia Times Online may be republished in any form without written
2003, Asia Times Online, 4305 Far East Finance Centre, 16 Harcourt Rd,
Central, Hong Kong